Osteosarcoma: Review of the various types with emphasis on recent advancements in imaging

Seminars in Musculoskeletal Radiology

Volumn 17, Issue 2, 2013, Pages 123-136

  Fox, Michaelg ^a   Trotta, Brianm ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

central osteosarcoma; MRI; osteosarcoma; PET; surface osteosarcoma

Indexed keywords

BONE TUMOR; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; POSITRON EMISSION TOMOGRAPHY; REVIEW; BONE NEOPLASMS; PROCEDURES;

BONE NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84877823306     PISSN: 10897860     EISSN: 1098898X     Source Type: Journal    
DOI: 10.1055/s-0033-1342969     Document Type: Article

References (99)

1. Klein M. J., Siegal G. P. Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol: 2006; 125 4 555 581
2. Wootton-Gorges S. L. MR imaging of primary bone tumors and tumor-like conditions in children. Magn Reson Imaging Clin N Am: 2009; 17 3 469 487, vi
3. Anbari K. K., Ierardi-Curto L. A., Silber J. S., et al. Two primary osteosarcomas in a patient with Rothmund-Thomson syndrome. Clin Orthop Relat Res: 2000; 378 213 223
4. Suresh S., Saifuddin A. Radiological appearances of appendicular osteosarcoma: a comprehensive pictorial review. Clin Radiol: 2007; 62 4 314 323 (Pubitemid 46291551)
5. Pahade J., Sekhar A., Shetty S. K. Imaging of malignant skeletal tumors. Cancer Treat Res: 2008; 143 367 422
6. Murphey M. D., Robbin M. R., McRae G. A., Flemming D. J., Temple H. T., Kransdorf M. J. The many faces of osteosarcoma. Radiographics: 1997; 17 5 1205 1231
7. Pringle J. AS. Osteosarcoma: the experiences of a specialist unit. Curr Diagn Pathol: 1996; 3 3 127 136 (Pubitemid 126833521)
8. Kim M. S., Lee S. Y., Cho W. H., et al. Initial tumor size predicts histologic response and survival in localized osteosarcoma patients. J Surg Oncol: 2008; 97 5 456 461
9. Greene F. LPD, Fleming I. D., Fritz A., Balch C. M., Haller D. G., Morrow M. AJCC Cancer Staging Manual. 6th ed. New York, NY Springer-Verlag: 2002
10. Spina V., Montanari N., Romagnoli R. Malignant tumors of the osteogenic matrix. Eur J Radiol: 1998; 27 01 S98 S109 (Pubitemid 28273261)
11. Kaste S. C., Liu T., Billups C. A., Daw N. C., Pratt C. B., Meyer W. H. Tumor size as a predictor of outcome in pediatric non-metastatic osteosarcoma of the extremity. Pediatr Blood Cancer: 2004; 43 7 723 728 (Pubitemid 39557707)
12. Lee J. A., Kim M. S., Kim D. H., et al. Relative tumor burden predicts metastasis-free survival in pediatric osteosarcoma. Pediatr Blood Cancer: 2008; 50 2 195 200
13. Wang C. S., Yin Q. H., Liao J. S., et al. Primary diaphyseal osteosarcoma in long bones: imaging features and tumor characteristics. Eur J Radiol: 2012; 81 11 3397 3403
14. Eftekhari F. Imaging assessment of osteosarcoma in childhood and adolescence: diagnosis, staging, and evaluating response to chemotherapy. Cancer Treat Res: 2009; 152 33 62
15. Cho W. H., Song W. S., Jeon D. G., et al. Differential presentations, clinical courses, and survivals of osteosarcomas of the proximal humerus over other extremity locations. Ann Surg Oncol: 2010; 17 3 702 708
16. Lee S. Y., Cho W. H., Song W. S., Park J. H. Different radiological findings with the same pathologic diagnosis due to different age in primary osteosarcoma. Acta Radiol: 2006; 47 8 841 844 (Pubitemid 44521244)
17. Rajiah P., Ilaslan H., Sundaram M. Imaging of sarcomas of pelvic bones. Semin Ultrasound CT MR: 2011; 32 5 433 441
18. Erlemann R., Sciuk J., Bosse A., et al. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Radiology: 1990; 175 3 791 796 (Pubitemid 20191948)
19. Zwaga T., Bovée J. V., Kroon H. M. Osteosarcoma of the femur with skip, lymph node, and lung metastases. Radiographics: 2008; 28 1 277 283
20. Wenaden A. E., Szyszko T. A., Saifuddin A. Imaging of periosteal reactions associated with focal lesions of bone. Clin Radiol: 2005; 60 4 439 456 (Pubitemid 40353021)
21. Kaste S. C., Pratt C. B., Cain A. M., Jones-Wallace D. J., Rao B. N. Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis: imaging features. Cancer: 1999; 86 8 1602 1608 (Pubitemid 29489798)
22. Burak Z., Moretti J. L., Ersoy O., et al. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression. J Nucl Med: 2003; 44 9 1394 1401 (Pubitemid 39663350)
23. McCarville M. B., Barton E. H., Cameron J. R., et al. The cause and clinical significance of central tumor photopenia on thallium scintigraphy of pediatric osteosarcoma of the extremity. AJR Am J Roentgenol: 2007; 188 2 572 578 (Pubitemid 46167761)
24. Bajpai J., Kumar R., Sreenivas V., et al. Prediction of chemotherapy response by PET-CT in osteosarcoma: correlation with histologic necrosis. J Pediatr Hematol Oncol: 2011; 33 7 e271 e278
25. Hamada K., Tomita Y., Inoue A., et al. Evaluation of chemotherapy response in osteosarcoma with FDG-PET. Ann Nucl Med: 2009; 23 1 89 95
26. Gaston L. L., Di Bella C., Slavin J., Hicks R. J., Choong P. F. 18F-FDG PET response to neoadjuvant chemotherapy for Ewing sarcoma and osteosarcoma are different. Skeletal Radiol: 2011; 40 8 1007 1015
27. Ye Z., Zhu J., Tian M., et al. Response of osteogenic sarcoma to neoadjuvant therapy: evaluated by 18F-FDG-PET. Ann Nucl Med: 2008; 22 6 475 480
28. Costelloe C. M., Macapinlac H. A., Madewell J. E., et al. 18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma. J Nucl Med: 2009; 50 3 340 347
29. Franzius C., Sciuk J., Daldrup-Link H. E., Jürgens H., Schober O. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med: 2000; 27 9 1305 1311
30. Franzius C., Daldrup-Link H. E., Sciuk J., et al. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Ann Oncol: 2001; 12 4 479 486 (Pubitemid 32472101)
31. Brisse H., Ollivier L., Edeline V., et al. Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment. Pediatr Radiol: 2004; 34 8 595 605 (Pubitemid 39162242)
32. Onikul E., Fletcher B. D., Parham D. M., Chen G. Accuracy of MR imaging for estimating intraosseous extent of osteosarcoma. AJR Am J Roentgenol: 1996; 167 5 1211 1215 (Pubitemid 26376237)
33. Gillespy T. III, Manfrini M., Ruggieri P., Spanier S. S., Pettersson H., Springfield D. S. Staging of intraosseous extent of osteosarcoma: correlation of preoperative CT and MR imaging with pathologic macroslides. Radiology: 1988; 167 3 765 767
34. Hoffer F. A., Nikanorov A. Y., Reddick W. E., et al. Accuracy of MR imaging for detecting epiphyseal extension of osteosarcoma. Pediatr Radiol: 2000; 30 5 289 298 (Pubitemid 30240806)
35. Saifuddin A. The accuracy of imaging in the local staging of appendicular osteosarcoma. Skeletal Radiol: 2002; 31 4 191 201 (Pubitemid 36075456)
36. Schima W., Amann G., Stiglbauer R., et al. Preoperative staging of osteosarcoma: efficacy of MR imaging in detecting joint involvement. AJR Am J Roentgenol: 1994; 163 5 1171 1175 (Pubitemid 24355712)
37. Sajadi K. R., Heck R. K., Neel M. D., et al. The incidence and prognosis of osteosarcoma skip metastases. Clin Orthop Relat Res: 2004; 426 92 96 (Pubitemid 39167113)
38. Kager L., Zoubek A., Kastner U., et al. Cooperative Osteosarcoma Study Group Skip metastases in osteosarcoma: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol: 2006; 24 10 1535 1541 (Pubitemid 46638775)
39. van der Woude H. J., Bloem J. L., Verstraete K. L., Taminiau A. H., Nooy M. A., Hogendoorn P. C. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery. AJR Am J Roentgenol: 1995; 165 3 593 598
40. Torricelli P., Montanari N., Spina V., et al. Dynamic contrast enhanced magnetic resonance imaging subtraction in evaluating osteosarcoma response to chemotherapy. Radiol Med (Torino): 2001; 101 3 145 151 (Pubitemid 32471852)
41. Guo J., Reddick W. E., Glass J. O., et al. Dynamic contrast-enhanced magnetic resonance imaging as a prognostic factor in predicting event-free and overall survival in pediatric patients with osteosarcoma. Cancer: 2012; 118 15 3776 3785
42. Yakushiji T., Oka K., Sato H., et al. Characterization of chondroblastic osteosarcoma: gadolinium-enhanced versus diffusion-weighted MR imaging. J Magn Reson Imaging: 2009; 29 4 895 900
43. Geirnaerdt M. J., Bloem J. L., van der Woude H. J., Taminiau A. H., Nooy M. A., Hogendoorn P. C. Chondroblastic osteosarcoma: characterisation by gadolinium-enhanced MR imaging correlated with histopathology. Skeletal Radiol: 1998; 27 3 145 153 (Pubitemid 28181759)
44. Yen C. H., Chang C. Y., Teng M. M., et al. Different and identical features of chondroblastic osteosarcoma and chondrosarcoma: highlights on radiography and magnetic resonance imaging. J Chin Med Assoc: 2009; 72 2 76 82
45. Nagata S., Nishimura H., Uchida M., Hayabuchi N., Zenmyou M., Harada H. Giant cell-rich osteosarcoma of the distal femur: radiographic and magnetic resonance imaging findings. Radiat Med: 2006; 24 3 228 232 (Pubitemid 351194344)
46. Bertoni F., Bacchini P., Donati D., Martini A., Picci P., Campanacci M. Osteoblastoma-like osteosarcoma. The Rizzoli Institute experience. Mod Pathol: 1993; 6 6 707 716 (Pubitemid 2014239)
47. Rosenberg Z. S., Lev S., Schmahmann S., Steiner G. C., Beltran J., Present D. Osteosarcoma: subtle, rare, and misleading plain film features. AJR Am J Roentgenol: 1995; 165 5 1209 1214
48. Tani T., Okada K., Shoji K., Hashimoto M., Sageshima M. Osteoblastoma-like osteosarcoma. Skeletal Radiol: 2000; 29 11 656 659 (Pubitemid 32042295)
49. Kallel R., Ayadi L., Toumi N., et al. Small cell osteosarcoma: a case report. Pathologica: 2009; 101 2 101 104
50. Mulligan M. E., Lewis D. R. Jr, Resnik C. S., Kumar D., Levine A. M. Small cell osteosarcoma of the ulna: a case report and review of the literature. J Hand Surg Am: 1999; 24 2 417 420 (Pubitemid 29149197)
51. Murphey M. D., wan Jaovisidha S., Temple H. T., Gannon F. H., Jelinek J. S., Malawer M. M. Telangiectatic osteosarcoma: radiologic-pathologic comparison. Radiology: 2003; 229 2 545 553 (Pubitemid 37310845)
52. Weiss A., Khoury J. D., Hoffer F. A., et al. Telangiectatic osteosarcoma: the St. Jude Children's Research Hospital's experience. Cancer: 2007; 109 8 1627 1637 (Pubitemid 46595699)
53. Kenan S., Ginat D. T., Steiner G. C. Dedifferentiated high-grade osteosarcoma originating from low-grade central osteosarcoma of the fibula. Skeletal Radiol: 2007; 36 4 347 351 (Pubitemid 46351396)
54. Andresen K. J., Sundaram M., Unni K. K., Sim F. H. Imaging features of low-grade central osteosarcoma of the long bones and pelvis. Skeletal Radiol: 2004; 33 7 373 379 (Pubitemid 39010910)
55. Lee H. J., Kim I. O., Kim W. S., Cheon J. E., Kim K. W., Yeon K. M. Metachronous multifocal osteosarcoma: a case report and literature review. Clin Imaging: 2002; 26 1 63 68 (Pubitemid 34119095)
56. Currall V. A., Dixon J. H. Synchronous multifocal osteosarcoma: case report and literature review. Sarcoma: 2006; 2006 53901
57. Nakayama E., Sugiura K., Kobayashi I., Oobu K., Ishibashi H., Kanda S. The association between the computed tomography findings, histologic features, and outcome of osteosarcoma of the jaw. J Oral Maxillofac Surg: 2005; 63 3 311 318 (Pubitemid 40269634)
58. Fu H. H., Zhuang Q. W., He J., Wang L. Z., He Y. Giant cell-rich osteosarcoma or giant cell reparative granuloma of the mandible? J Craniofac Surg: 2011; 22 3 1136 1139
59. Murphey M. D., Jelinek J. S., Temple H. T., Flemming D. J., Gannon F. H. Imaging of periosteal osteosarcoma: radiologic-pathologic comparison. Radiology: 2004; 233 1 129 138 (Pubitemid 39280967)
60. Vanel D., Picci P., De Paolis M., Mercuri M. Radiological study of 12 high-grade surface osteosarcomas. Skeletal Radiol: 2001; 30 12 667 671 (Pubitemid 33138699)
61. Dönmez F. Y., Tüzün U., Başaran C., Tunaci M., Bilgiç B., Acunaş G. MRI findings in parosteal osteosarcoma: correlation with histopathology. Diagn Interv Radiol: 2008; 14 3 142 152
62. Jelinek J. S., Murphey M. D., Kransdorf M. J., Shmookler B. M., Malawer M. M., Hur R. C. Parosteal osteosarcoma: value of MR imaging and CT in the prediction of histologic grade. Radiology: 1996; 201 3 837 842 (Pubitemid 26392639)
63. Azura M., Vanel D., Alberghini M., Picci P., Staals E., Mercuri M. Parosteal osteosarcoma dedifferentiating into telangiectatic osteosarcoma: importance of lytic changes and fluid cavities at imaging. Skeletal Radiol: 2009; 38 7 685 690
64. Okada K., Frassica F. J., Sim F. H., Beabout J. W., Bond J. R., Unni K. K. Parosteal osteosarcoma. A clinicopathological study. J Bone Joint Surg Am: 1994; 76 3 366 378
65. Johnson K., Davies A. M., Evans N., Grimer R. J. Imaging recurrent parosteal osteosarcoma. Eur Radiol: 2001; 11 3 460 466 (Pubitemid 32755476)
66. Shuhaibar H., Friedman L. Dedifferentiated parosteal osteosarcoma with high-grade osteoclast-rich osteogenic sarcoma at presentation. Skeletal Radiol: 1998; 27 10 574 577 (Pubitemid 28505165)
67. Bertoni F., Bacchini P., Staals E. L., Davidovitz P. Dedifferentiated parosteal osteosarcoma: the experience of the Rizzoli Institute. Cancer: 2005; 103 11 2373 2382 (Pubitemid 40686584)
68. Lin J., Yao L., Mirra J. M., Bahk W. J. Osteochondromalike parosteal osteosarcoma: a report of six cases of a new entity. AJR Am J Roentgenol: 1998; 170 6 1571 1577 (Pubitemid 28237652)
69. Staals E. L., Bacchini P., Bertoni F. High-grade surface osteosarcoma: a review of 25 cases from the Rizzoli Institute. Cancer: 2008; 112 7 1592 1599 (Pubitemid 351441173)
70. Kyriakos M. Intracortical osteosarcoma. Cancer: 1980; 46 11 2525 2533 (Pubitemid 11253716)
71. Hermann G., Klein M. J., Springfield D., Abdelwahab I. F., Dan S. J. Intracortical osteosarcoma; two-year delay in diagnosis. Skeletal Radiol: 2002; 31 10 592 596 (Pubitemid 36082785)
72. Hasegawa T., Shimoda T., Yokoyama R., Beppu Y., Hirohashi S., Maeda S. Intracortical osteoblastic osteosarcoma with oncogenic rickets. Skeletal Radiol: 1999; 28 1 41 45 (Pubitemid 29134557)
73. Logan P. M., Mitchell M. J., Munk P. L. Imaging of variant osteosarcomas with an emphasis on CT and MR imaging. AJR Am J Roentgenol: 1998; 171 6 1531 1537 (Pubitemid 28531620)
74. Kaushik S., Smoker W. R., Frable W. J. Malignant transformation of fibrous dysplasia into chondroblastic osteosarcoma. Skeletal Radiol: 2002; 31 2 103 106 (Pubitemid 36067517)
75. Abdelwahab I. F., Klein M. J., Hermann G., Steiner G. C., Yang D. C. Osteosarcoma arising in a desmoplastic fibroma of the proximal tibia. AJR Am J Roentgenol: 2002; 178 3 613 615 (Pubitemid 34178139)
76. Brien E. W., Mirra J. M., Kessler S., Suen M., Ho J. K., Yang W. T. Benign giant cell tumor of bone with osteosarcomatous transformation ("dedifferentiatedo" primary malignant GCT): report of two cases. Skeletal Radiol: 1997; 26 4 246 255 (Pubitemid 27197065)
77. Iwasawa T., Tanaka Y., Aida N., Okuzumi S., Nishihira H., Nishimura G. Microscopic intraosseous extension of osteosarcoma: assessment on dynamic contrast-enhanced MRI. Skeletal Radiol: 1997; 26 4 214 221 (Pubitemid 27197059)
78. Ryan S. P., Weinberger E., White K. S., et al. MR imaging of bone marrow in children with osteosarcoma: effect of granulocyte colony-stimulating factor. AJR Am J Roentgenol: 1995; 165 4 915 920
79. Han G., Wang Y., Bi W. Z., et al. Magnetic resonance imaging is appropriate for determining the osteotomy plane for appendicular osteosarcoma after neoadjuvant chemotherapy. Med Oncol: 2012; 29 2 1347 1353
80. Masrouha K. Z., Musallam K. M., Samra A. B., et al. Correlation of non-mass-like abnormal MR signal intensity with pathological findings surrounding pediatric osteosarcoma and Ewing's sarcoma. Skeletal Radiol: 2012; 41 11 1453 1461
81. Shin K. H., Moon S. H., Suh J. S., Yang W. I. Tumor volume change as a predictor of chemotherapeutic response in osteosarcoma. Clin Orthop Relat Res: 2000; 376 200 208
82. Holscher H. C., Bloem J. L., Vanel D., et al. Osteosarcoma: chemotherapy-induced changes at MR imaging. Radiology: 1992; 182 3 839 844
83. Holscher H. C., Bloem J. L., van der Woude H. J., et al. Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy? Clin Radiol: 1995; 50 6 384 390
84. Ongolo-Zogo P., Thiesse P., Sau J., et al. Assessment of osteosarcoma response to neoadjuvant chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99m skeletal angioscintigraphy. Eur Radiol: 1999; 9 5 907 914
85. Reddick W. E., Wang S., Xiong X., et al. Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma. Cancer: 2001; 91 12 2230 2237 (Pubitemid 32552807)
86. Dyke J. P., Panicek D. M., Healey J. H., et al. Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imaging. Radiology: 2003; 228 1 271 278 (Pubitemid 36736103)
87. Reddick W. E., Bhargava R., Taylor J. S., Meyer W. H., Fletcher B. D. Dynamic contrast-enhanced MR imaging evaluation of osteosarcoma response to neoadjuvant chemotherapy. J Magn Reson Imaging: 1995; 5 6 689 694
88. Hayashida Y., Yakushiji T., Awai K., et al. Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial results. Eur Radiol: 2006; 16 12 2637 2643 (Pubitemid 44823917)
89. Oka K., Yakushiji T., Sato H., Hirai T., Yamashita Y., Mizuta H. The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient. Skeletal Radiol: 2010; 39 2 141 146
90. Körholz D., Wirtz I., Vosberg H., Rüther W., Jürgens H., Göbel U. The role of bone scintigraphy in the follow-up of osteogenic sarcoma. Eur J Cancer: 1996; 32A 3 461 464
91. Herrlin K., Willén H., Wiebe T. Flare phenomenon in osteosarcoma after complete remission. J Nucl Med: 1995; 36 8 1429 1431
92. Bakri D., Bar-Shalom R., Ben Arush M. W., Postovsky S. Value of routine bone scans in patients with bone sarcomas before local treatment. J Pediatr Hematol Oncol: 2011; 33 2 103 106
93. Cheon G. J., Kim M. S., Lee J. A., et al. Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI. J Nucl Med: 2009; 50 9 1435 1440
94. Schulte M., Brecht-Krauss D., Werner M., et al. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET. J Nucl Med: 1999; 40 10 1637 1643 (Pubitemid 29471153)
95. Miwa S., Shirai T., Taki J., et al. Use of 99mTc-MIBI scintigraphy in the evaluation of the response to chemotherapy for osteosarcoma: comparison with 201Tl scintigraphy and angiography. Int J Clin Oncol: 2011; 16 4 373 378
96. Ayerza M. A., Farfalli G. L., Aponte-Tinao L., Muscolo D. L. Does increased rate of limb-sparing surgery affect survival in osteosarcoma? Clin Orthop Relat Res: 2010; 468 11 2854 2859
97. Hao Y. K., Zhang Y. K., Yang Z. P., Li X., Yang Q., Li J. M. The accuracy of magnetic resonance imaging in determining the osteotomy plane in osteosarcoma. Orthopedics: 2008; 31 6 544
98. Chen W., Zhu H., Zhang L., et al. Primary bone malignancy: effective treatment with high-intensity focused ultrasound ablation. Radiology: 2010; 255 3 967 978
99. Garner H. W., Kransdorf M. J., Peterson J. J. Posttherapy imaging of musculoskeletal neoplasms. Radiol Clin North Am: 2011; 49 6 1307 1323, vii